480 related articles for article (PubMed ID: 26169974)
21. Childhood maltreatment severity is associated with elevated C-reactive protein and body mass index in adults with schizophrenia and bipolar diagnoses.
Aas M; Dieset I; Hope S; Hoseth E; Mørch R; Reponen E; Steen NE; Laskemoen JF; Ueland T; Aukrust P; Agartz I; Andreassen OA; Melle I
Brain Behav Immun; 2017 Oct; 65():342-349. PubMed ID: 28619247
[TBL] [Abstract][Full Text] [Related]
22. C-Reactive Protein: Higher During Acute Psychotic Episodes and Related to Cortical Thickness in Schizophrenia and Healthy Controls.
Jacomb I; Stanton C; Vasudevan R; Powell H; O'Donnell M; Lenroot R; Bruggemann J; Balzan R; Galletly C; Liu D; Weickert CS; Weickert TW
Front Immunol; 2018; 9():2230. PubMed ID: 30364161
[TBL] [Abstract][Full Text] [Related]
23. Serum C-reactive protein in adolescence and risk of schizophrenia in adulthood: A prospective birth cohort study.
Metcalf SA; Jones PB; Nordstrom T; Timonen M; Mäki P; Miettunen J; Jääskeläinen E; Järvelin MR; Stochl J; Murray GK; Veijola J; Khandaker GM
Brain Behav Immun; 2017 Jan; 59():253-259. PubMed ID: 27622678
[TBL] [Abstract][Full Text] [Related]
24. Do all schizophrenia patients need antipsychotic treatment continuously throughout their lifetime? A 20-year longitudinal study.
Harrow M; Jobe TH; Faull RN
Psychol Med; 2012 Oct; 42(10):2145-55. PubMed ID: 22340278
[TBL] [Abstract][Full Text] [Related]
25. The effect of antipsychotic drugs on nonspecific inflammation markers in the first episode of schizophrenia.
Stefanović V; Mihajlović G; Nenadović M; Dejanović SD; Borovcanin M; Trajković G
Vojnosanit Pregl; 2015 Dec; 72(12):1085-92. PubMed ID: 26898032
[TBL] [Abstract][Full Text] [Related]
26. Redefining peripheral inflammation signature in schizophrenia based on the real-world FACE-SZ cohort.
Fond G; Sunhary de Verville PL; Richieri R; Etchecopar-Etchart D; Korchia T; Faugere M; Godin O; Schürhoff F; Berna F; Aouizerate B; Capdevielle D; Chereau I; Clauss-Kobayashi J; Coulon N; Dorey JM; Dubertret C; Dubreucq J; Mallet J; Misdrahi D; Passerieux C; Pignon B; Rey R; Urbach M; Leboyer M;
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Dec; 111():110335. PubMed ID: 33933539
[TBL] [Abstract][Full Text] [Related]
27. C-reactive protein concentrations across the mood spectrum in bipolar disorder: a systematic review and meta-analysis.
Fernandes BS; Steiner J; Molendijk ML; Dodd S; Nardin P; Gonçalves CA; Jacka F; Köhler CA; Karmakar C; Carvalho AF; Berk M
Lancet Psychiatry; 2016 Dec; 3(12):1147-1156. PubMed ID: 27838212
[TBL] [Abstract][Full Text] [Related]
28. Peripheral inflammatory and neurotrophic biomarkers of cognitive impairment in schizophrenia: a meta-analysis.
Bora E
Psychol Med; 2019 Sep; 49(12):1971-1979. PubMed ID: 31284882
[TBL] [Abstract][Full Text] [Related]
29. Morning cortisol levels in schizophrenia and bipolar disorder: a meta-analysis.
Girshkin L; Matheson SL; Shepherd AM; Green MJ
Psychoneuroendocrinology; 2014 Nov; 49():187-206. PubMed ID: 25108162
[TBL] [Abstract][Full Text] [Related]
30. Increased annexin-V and decreased TNF-α serum levels in chronic-medicated patients with schizophrenia.
Francesconi LP; Ceresér KM; Mascarenhas R; Stertz L; Gama CS; Belmonte-de-Abreu P
Neurosci Lett; 2011 Sep; 502(3):143-6. PubMed ID: 21741441
[TBL] [Abstract][Full Text] [Related]
31. Association of Serum Trace Elements with Schizophrenia and Effects of Antipsychotic Treatment.
Chen X; Li Y; Zhang T; Yao Y; Shen C; Xue Y
Biol Trace Elem Res; 2018 Jan; 181(1):22-30. PubMed ID: 28470477
[TBL] [Abstract][Full Text] [Related]
32. Increased serum S100B levels in chronic schizophrenic patients on long-term clozapine or typical antipsychotics.
Qi LY; Xiu MH; Chen DC; Wang F; Kosten TA; Kosten TR; Zhang XY
Neurosci Lett; 2009 Sep; 462(2):113-7. PubMed ID: 19539717
[TBL] [Abstract][Full Text] [Related]
33. A preliminary analysis of association between the down-regulation of microRNA-181b expression and symptomatology improvement in schizophrenia patients before and after antipsychotic treatment.
Song HT; Sun XY; Zhang L; Zhao L; Guo ZM; Fan HM; Zhong AF; Niu W; Dai YH; Zhang LY; Shi Z; Liu XP; Lu J
J Psychiatr Res; 2014 Jul; 54():134-40. PubMed ID: 24694668
[TBL] [Abstract][Full Text] [Related]
34. Abnormal white matter microstructure in drug-naive first episode schizophrenia patients before and after eight weeks of antipsychotic treatment.
Zeng B; Ardekani BA; Tang Y; Zhang T; Zhao S; Cui H; Fan X; Zhuo K; Li C; Xu Y; Goff DC; Wang J
Schizophr Res; 2016 Apr; 172(1-3):1-8. PubMed ID: 26852402
[TBL] [Abstract][Full Text] [Related]
35. Birth by cesarean section and schizophrenia: results from the multicenter FACE-SZ data-set.
Fond G; Bulzacka E; Boyer L; Llorca PM; Godin O; Brunel L; Andrianarisoa MG; Aouizerate B; Berna F; Capdevielle D; Chereau I; Denizot H; Dorey JM; Dubertret C; Dubreucq J; Faget C; Gabayet F; Le Strat Y; Micoulaud-Franchi JA; Misdrahi D; Rey R; Richieri R; Roger M; Passerieux C; Schandrin A; Urbach M; Vidalhet P; Schürhoff F; Leboyer M;
Eur Arch Psychiatry Clin Neurosci; 2017 Sep; 267(6):587-594. PubMed ID: 27349652
[TBL] [Abstract][Full Text] [Related]
36. Does treatment of schizophrenia with antipsychotic medications eliminate or reduce psychosis? A 20-year multi-follow-up study.
Harrow M; Jobe TH; Faull RN
Psychol Med; 2014 Oct; 44(14):3007-16. PubMed ID: 25066792
[TBL] [Abstract][Full Text] [Related]
37. Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics.
Xiu MH; Hui L; Dang YF; Hou TD; Zhang CX; Zheng YL; Chen DC; Kosten TR; Zhang XY
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1508-12. PubMed ID: 19720106
[TBL] [Abstract][Full Text] [Related]
38. Association of adiponectin and metabolic syndrome among patients taking atypical antipsychotics for schizophrenia: a cohort study.
Bai YM; Chen TT; Yang WS; Chi YC; Lin CC; Liou YJ; Wang YC; Su TP; Chou P; Chen JY
Schizophr Res; 2009 Jun; 111(1-3):1-8. PubMed ID: 19409756
[TBL] [Abstract][Full Text] [Related]
39. Could CRP be a differential biomarker of illness stages in schizophrenia? A systematic review and meta-analysis.
Lestra V; Romeo B; Martelli C; Benyamina A; Hamdani N
Schizophr Res; 2022 Aug; 246():175-186. PubMed ID: 35785580
[TBL] [Abstract][Full Text] [Related]
40. Increase systemic levels of IL-23 as a possible constitutive marker in schizophrenia.
Borovcanin M; Jovanovic I; Dejanovic SD; Radosavljevic G; Arsenijevic N; Lukic ML
Psychoneuroendocrinology; 2015 Jun; 56():143-7. PubMed ID: 25827958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
